Component
Mouse peptide/histidine transporter Pht1 / Slc15a4
Context-specific entity; species, compartment and exposure are stated on each claim.
4 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Deleting Pht1 reduced histidine uptake in mouse brain slices by about half; Pept2 expression increased approximately twofold.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Pht1-null and matched wild-type adult mice; brain slices and transporter expression.
- limitations
- Genetic deletion is not dietary histidine deficiency.
- nutrient_topic
- L-Histidine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Histidine
- plain_language
- Loss of one transporter altered uptake even with a compensatory response.
- primary_references
- A novel role for PHT1 in the disposition of l-histidine in brain: In vitro slice and in vivo pharmacokinetic studies in wildtype and Pht1 null mice. · 2017 · https://pubmed.ncbi.nlm.nih.gov/27845049/ · DOI 10.1016/j.bcp.2016.11.012
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Histidine: supply, catabolism, histamine, receptors and cross-nutrient mechanisms (2026-09-19) · lines 90–96
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Pht1-null and matched wild-type adult mice; brain slices and transporter expression. · source_derived_draft · unverified_draft
## histidine-pht1-brain-uptake Loss of one transporter altered uptake even with a compensatory response. Deleting Pht1 reduced histidine uptake in mouse brain slices by about half; Pept2 expression increased approximately twofold. Model: Pht1-null and matched wild-type adult mice; brain slices and transporter expression. Limitations: Genetic deletion is not dietary histidine deficiency. Evidence access: Primary full text A novel role for PHT1 in the disposition of l-histidine in brain: In vitro slice and in vivo pharmacokinetic studies in wildtype and Pht1 null mice. · 2017 · https://pubmed.ncbi.nlm.nih.gov/27845049/ · DOI 10.1016/j.bcp.2016.11.012
Complete structured claim and evidenceFive minutes after intravenous histidine, Pht1-null mouse brain parenchyma contained 28-48 percent less tracer-associated histidine than wild type, despite comparable plasma time courses and no corresponding CSF difference.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Mouse knockout and intravenous pharmacokinetics.
- limitations
- Acute tracer distribution cannot define steady-state human brain deficiency.
- nutrient_topic
- L-Histidine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Histidine
- plain_language
- A normal circulating profile did not guarantee the same tissue exposure.
- primary_references
- A novel role for PHT1 in the disposition of l-histidine in brain: In vitro slice and in vivo pharmacokinetic studies in wildtype and Pht1 null mice. · 2017 · https://pubmed.ncbi.nlm.nih.gov/27845049/ · DOI 10.1016/j.bcp.2016.11.012
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Histidine: supply, catabolism, histamine, receptors and cross-nutrient mechanisms (2026-09-19) · lines 98–104
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse knockout and intravenous pharmacokinetics. · source_derived_draft · unverified_draft
## histidine-pht1-compartments A normal circulating profile did not guarantee the same tissue exposure. Five minutes after intravenous histidine, Pht1-null mouse brain parenchyma contained 28-48 percent less tracer-associated histidine than wild type, despite comparable plasma time courses and no corresponding CSF difference. Model: Mouse knockout and intravenous pharmacokinetics. Limitations: Acute tracer distribution cannot define steady-state human brain deficiency. Evidence access: Primary full text A novel role for PHT1 in the disposition of l-histidine in brain: In vitro slice and in vivo pharmacokinetic studies in wildtype and Pht1 null mice. · 2017 · https://pubmed.ncbi.nlm.nih.gov/27845049/ · DOI 10.1016/j.bcp.2016.11.012
Complete structured claim and evidenceMouse experiments attributed TLR-triggered cytokine production to functional Slc15a4 transport and linked Slc15a4 loss with reduced pathogenic antibody production.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Mouse genetic/transport-function study.
- limitations
- Later human TASL-tethering experiments provide a scaffold bypass; this is not proof that dietary histidine controls autoimmunity.
- nutrient_topic
- L-Histidine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Histidine
- plain_language
- The original model linked transporter function with the immune response.
- primary_references
- The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production. · 2014 · https://pubmed.ncbi.nlm.nih.gov/25238095/ · DOI 10.1016/j.immuni.2014.08.011
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Histidine: supply, catabolism, histamine, receptors and cross-nutrient mechanisms (2026-09-19) · lines 370–376
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse genetic/transport-function study. · source_derived_draft · unverified_draft
## histidine-slc15a4-mouse-cytokines The original model linked transporter function with the immune response. Mouse experiments attributed TLR-triggered cytokine production to functional Slc15a4 transport and linked Slc15a4 loss with reduced pathogenic antibody production. Model: Mouse genetic/transport-function study. Limitations: Later human TASL-tethering experiments provide a scaffold bypass; this is not proof that dietary histidine controls autoimmunity. Evidence access: Primary abstract The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production. · 2014 · https://pubmed.ncbi.nlm.nih.gov/25238095/ · DOI 10.1016/j.immuni.2014.08.011
Complete structured claim and evidenceSlc15a4 loss disturbed mouse B-cell endolysosomal pH regulation and was associated with disrupted mTOR signaling and the IRF7/type-I-interferon circuit.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Mouse B-cell genetic experiments and lupus model.
- limitations
- v-ATPase integrity was proposed rather than definitively established as the sole cause. Histidine intake was not the manipulation.
- nutrient_topic
- L-Histidine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Histidine
- plain_language
- Losing a transporter-associated system changed the local organelle environment and immune signaling.
- primary_references
- The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production. · 2014 · https://pubmed.ncbi.nlm.nih.gov/25238095/ · DOI 10.1016/j.immuni.2014.08.011
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Histidine: supply, catabolism, histamine, receptors and cross-nutrient mechanisms (2026-09-19) · lines 362–368
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse B-cell genetic experiments and lupus model. · source_derived_draft · unverified_draft
## histidine-slc15a4-mouse-ph Losing a transporter-associated system changed the local organelle environment and immune signaling. Slc15a4 loss disturbed mouse B-cell endolysosomal pH regulation and was associated with disrupted mTOR signaling and the IRF7/type-I-interferon circuit. Model: Mouse B-cell genetic experiments and lupus model. Limitations: v-ATPase integrity was proposed rather than definitively established as the sole cause. Histidine intake was not the manipulation. Evidence access: Primary abstract The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production. · 2014 · https://pubmed.ncbi.nlm.nih.gov/25238095/ · DOI 10.1016/j.immuni.2014.08.011
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.